What the numbers say - 2015 in the life of Maven7

2015 is slowly coming to an end, and while we are already fully focused on the future, let us reminisce about the year behind us. Maven7 has had an exciting year, packed with great challenges, great projects and even greater moments.

Strategically, 2015 was of key importance as the company received a set of Series A funding, making the total investment in Maven7 $2.3 million to date.

Team-wise, we have grown to 32 with the joining of 8 new mavens across our Development, Analyst, Sales and Marketing departments. With this expansion came an increase in our consumption as well. We have gulped over 11,000 liters of water, 10,300 cups of coffee and over 5,200 cups of tea. Oh and about 600 shakers of whey protein (gains gains gains!!!). Let's not talk about food, we eat a lot…especially when waiting for flights, all 56 of them this year.

We need to fuel ourselves though, this year we have passed the milestone of "220,000 work connections analyzed" with OrgMapper, and our Diktio Labs team was on a roll as well. They have analyzed over 20 million Facebook likes and 38 million Tweets to date. No wonder we need those 7,300 cups of coffee…

If you were to call us all at the same time, you could expect 8 iPhones and 24 Androids to ring, but call us before 7 P.M., otherwise we might be at an ice-hockey match or a pub quiz. Our analyst, Balázs attended 43 ice-hockey games this year and as far as our trivia-fondness goes, our quiz-enthusiasts answered over 2,000 questions (most of them correctly). We are a fun-loving bunch, but we also put great emphasis on supporting charities and other serious causes too, hence the heroes and heroines of the office donated 15 liters of blood this year.

All in all, 2015 was a challenging, but fun year in the life of Maven7 and we can hardly wait for the new year to come with everything it holds for us. 

Happy Holidays and see you in 2016!

Fans voted the US and Iran the most disliked World Cup teams

According to a 19-country study conducted by YouGov and Upshot, the good ol' US of A and Iran are the least favored teams in the world's favorite sporting event, the World Cup, starting these very minutes.

We thought that the question "Which Team Are You Rooting Against?" deserved our full attention, so we took to analyzing the results and drew up a pretty network map. Read this New York Times article for more information regarding the outcomes of this question (including the seemingly obvious ties between soccer and politics) and others.

Primus Capital invests in the expansion of Maven7

Official press release on the recent happenings in our company's life:

Budapest, Hungary – Boston, MA
Primus Capital Fund Management Ltd. is investing more than 170 million forints (approx. 750,000 US dollars) acquiring a minority stake in Maven Seven Network Research Ltd. (Maven7), a provider of unique network research-based analyses and services. Through the capital investment, the 4-year-old company will further develop its online diagnostic tool, OrgMapper, and take it to Western European and overseas markets. It will also strengthen the sales activities of its US subsidiary and further develop its network analysis services for the media and pharmaceutical sectors.

Maven7 applies the latest results and innovations in network science to the business environment. Among its co-founders are such internationally acclaimed scientists of the discipline as Albert-László Barabási (Northeastern and Harvard Universities) and Tamás Vicsek (Hungarian Academy of Sciences, ELTE), who rightfully ensure the company's academic credibility.

Maven7 supports business decisions by transforming large amounts of hard-to-interpret data into actionable business intelligence.

The company's online Software as a Service (SaaS) platform, OrgMapper, allows its users, primarily in the business consulting sector, to conduct analyses in organizational development, the media, and the pharmaceutical industry, on the basis of which consultancies can provide M&A advisory, change management and other services to their customers.


Maven7 is the 10th investment of Primus Capital. "International competitiveness and execution built on the expertise of Central European physicists and engineers – this is the strategy of Maven7 and Primus Capital. We are proud to be working with such a fast-growing company and a team of extremely talented professionals in order to achieve international growth", added Zoltán Bruckner, investment director at Primus Capital.